|
|
Cell Culture & Upstream ProcessingLearn how to accelerate your cell line development programs by applying technologies to help reduce development timelines and workflows while managing instability. Hear case studies on multi-faceted approaches to developing fast and efficient processes that control quality and improve manufacturability. Discover how to apply quality by design to balance product quality and robustness during cell line or process changes and use best practices to avoid pitfalls during the application of quality by design. Investigate tools and techniques to optimize your media design, development and feed strategies. Hear proven strategies to help you overcome the impact of upstream advances in process development. - Approaches to Reduce Timelines and Manage Instability in Cell Line Development
- Achieving 10+ Grams Per Liter and the Challenges on Process Development
- Exploring Different Development Paths to Higher Productivity and Improved Quality
Advisory Board - Timothy S. Charlebois, Ph.D., Senior Director, Drug Substance Development, Wyeth BioPharma
- Geoffrey Francis, Ph.D., Chief Scientist, Applied R&D, Novozyme BioPharma AV Ltd., Australia
- Laurel Donahue-Hjelle, Ph.D., Director of Cell Line Development, Invitrogen Corporation
- Kevin J. Kayser, Ph.D., R&D Manager, Cell Line Engineering, SAFC Biosciences
- Dennis M. Kraichely, Ph.D., Principal Research Scientist, Expression Technologies, Centocor, Inc.
- Suzanne Kuo, Ph.D., Senior Engineer, Late Stage Cell Culture Process Development, Genentech, Inc.
- John Mott, Ph.D., Director, Bioprocess R&D, Cell Line Development, Pfizer Global Biologics
- Charles Sardonini, Ph.D., Associate Director, Process Engineering/Development, Genzyme Corporation
- Thomas Seewoester, Ph.D., Director, Process Development, Amgen Inc.
- Gary Welch, Director, Process Development, Abbott Bioresearch Center
View the Agenda View the Other Tracks

|
|